Delta variant expected to become dominant US strain, CDC says

The delta variant first detected in India will likely become the dominant U.S. strain, the CDC director said — who stressed vaccination to stay protected.

Lawmakers seek 9/11-style commission to probe COVID-19 pandemic

A push is underway on Capitol Hill and beyond for a full-blown investigation of the coronavirus outbreak by a national commission like the one that looked into 9/11.

Minnesota reports 142 new COVID-19 cases, 4 deaths Thursday as positivity rate declines to 1.8%

The Minnesota Department of Health reported 142 new COVID-19 cases and four additional deaths Thursday as the state’s seven-day rolling average test positivity rate declines to 1.8%, well below the caution threshold.

Affordable Care Act: Supreme Court dismisses challenge to health law

The Supreme Court on Thursday dismissed a challenge to the Affordable Care Act, preserving insurance coverage for millions of Americans.

COVID vaccine proof: Wisconsin bill forbids requiring it

The Wisconsin Assembly on Wednesday passed a Republican-backed bill that would prohibit businesses, colleges and universities, governments and anyone else in the state from requiring proof of COVID-19 vaccination.

COVID-19 vaccinations slow down as infectious delta variant spreads

One major concern is the highly contagious and potentially more severe delta variant of the coronavirus that originated in India. While health officials say the vaccines are effective against it, the fear is that it will lead to outbreaks in states with lower vaccination rates.

More than 3 million Minnesotans have had at least 1 dose of COVID-19 vaccine

The state department of health reported that 3,005,706 Minnesotans have had at least one dose of the COVID-19 vaccine, and 2,774,889 are fully vaccinated.

Advocates say system failed in case of Brooklyn Park homicide

Records show the suspect accused of fatally striking his neighbor with his car has a history of violent behavior and severe mental illness.

Some hospitals seeing no new COVID-19 patients, but delta variant could undo progress

Some hospitals are going days without any new COVID-19 patients for the first time in more than a year, but the milestone could be undone by the delta variant becoming more dominant in the U.S., putting unvaccinated Americans at risk.

Study: Delta variant can reduce Pfizer, Astrazeneca COVID-19 vaccine effectiveness

Recently released studies out of the U.K. found Pfizer’s and Astrazeneca’s COVID-19 vaccines effectiveness was diminished somewhat by the Delta variant, but both vaccines remained protective against hospitalization.

Minnesota reports 118 new COVID-19 cases, 5 deaths Monday

The Minnesota Department of Health reported 118 new cases of COVID-19 and five additional deaths Monday as the state nearly surpasses three million people with at least one vaccine dose.

Kamala Harris visits South Carolina in US COVID-19 vaccine push

Vice President Kamala Harris landed in Greenville as part of the Biden administration’s effort to promote its ongoing coronavirus vaccination campaign.

Novavax says COVID-19 vaccine about 90% effective in large study

A Novavax large-stage study in the U.S. and Mexico found that its COVID-19 vaccine was about 90% effective overall and protected against variants.

Minnesota reports 173 new COVID-19 cases and 9 new deaths on Sunday

The Minnesota Department of Health reported 174 new cases of COVID-19 and seven more deaths Saturday as the state’s seven-day average positivity rate continues to steadily decline. 

Youth suicide attempts increased 31% amid COVID-19 pandemic, CDC says

Suicide attempts among adolescents increased 31% amid the COVID-19 pandemic and over 50% of that was among females, according to the U.S. Centers for Disease Control and Prevention.

Short breaks may help brain learn new skills, NIH study says

Researchers studying brain activity at the NIH found that rest during an activity may strengthen a person’s ability to do the skill.

U.S. vaccine surplus grows by the day; expiration dates loom

The U.S. is confronted with an ever-growing surplus of COVID-19 vaccines, looming expiration dates and stubbornly lagging demand at a time when the developing world is clamoring for doses to stem a rise in infections.

FDA OKs just 10M J&J vaccine doses from troubled Baltimore plant

Two batches of Johnson & Johnson’s COVID vaccine manufactured at the troubled Baltimore plant have been authorized for use by the FDA. But many more must be thrown out.